EDITORIAL

Erratum

BioBoard

JAPAN
•  New broad strain anti-influenza macrocyclic peptide therapeutic developed

LAOS
•  bioCSL supports public health efforts in Laos with donation of more than 700,000 doses of seasonal influenza vaccine

SINGAPORE
•  New NUS spin-off company to reduce cancer death and disease burden through real time cancer diagnosis

THAILAND
•  Bats protect rice fields against pests

THE PHILIPPINES
•  Hotter nights may cause rice yields to fall
•  Study suggests shift in strategy on pneumonia vaccinations

BANGLADESH
•  Mutant bird flu worries Bangladeshi scientists

EUROPE
•  Novel strategy to molecular anticancer therapy

SRI LANKA
•  Evolving dengue strains plague Sri Lanka

UNITED STATES
•  Gene sequencing project discovers mutations tied to deadly brain tumors in young children
•  Laboratory-grown vaginas implanted in patients
•  Stem cells in circulating blood affect cardiovascular health
•  New point of attack on HIV for vaccine development
•  GAIM-changing molecules to combat Alzheimer’s disease and other neurodegenerative disorders discovered
•  Breath analysis offers non-invasive method to detect early lung cancer
•  Researchers discover new genetic brain disorder in humans

EYE ON CHINA
•  WuXi PharmaTech receives honorable mention at 2014 ISPE Facility of the Year Awards
•  UCLA launches joint venture with Chinese firm to open sophisticated lab in Shanghai
•  Mucosis enters strategic partnership with Changchun BCHT Biotechnology of China
•  Catalent enters biosimilar development collaboration with Zhejiang Hisun Pharma
•  Bio-Techne acquires Shanghai PrimeGene Bio-Tech
•  Sinovac receives notification of China government grant for EV71 vaccine project
•  Sinovac enters technology transfer agreement with intravacc to develop and commercialize Sabin Inactivated Polio Vaccine (sIPV)
•  WuXi PharmaTech breaks ground on new cell therapy manufacturing facility
•  China study to see how Pacific current affects climate
•  ResearchDx receives Strategic Partner Award from WuXi AppTec
•  iBio receives patent allowance in China for fusion protein compositions and technology

FEATURES
•  Neuroscience and the Law
•  Neurological Impairment and the Capacity to Consent to Participate in Research
•  Ethical Responsibility to Manage Incidental Findings in Brain Imaging Research
•  The Impact of Discrimination on Research into Depression

PEOPLE WATCH
•  Microchip Innovations

INSIDE INDUSTRY
•  Sanaria® PfSPZ malaria vaccine wins 2014 Vaccine Industry Excellence Award for "Best Prophylactic Vaccine"
•  Analytik Jena AG planning merger by absorption of CyBio AG
•  Sanguine to begin work with Mayo Clinic Bioservices to accelerate individualized medicine research and development
•  Thermo Fisher Scientific and the National University of Singapore Sign MOU to create strategic alliance to accelerate life science research in Singapore
•  Sun Pharma to acquire Ranbaxy in a US$ 4 billion landmark transaction
•  Meda and Valeant terminates joint ventures
•  Crown Bioscience enters Japanese market via strategic partnership with Shin Nippon Biomedical Laboratories
•  Quintiles and Biogen Idec enter comprehensive clinical development partnership
•  Registration opened for Oxford Global’s Drug Discovery USA Congress
•  Speakers for Oxford Global’s Microbiology & Infectious Diseases Congress released
•  Daiichi Sankyo and UC San Francisco announce collaboration in drug discovery research for neurodegenerative diseases
•  Funding crunch hits neglected diseases plan
•  Coca-Cola partners with A*STAR to expand technology presence in Singapore
•  DaVita expands kidney care services in Malaysia acquires Sinar Indentiti clinics in Seremban

•  CONFERENCE CALENDAR